AKTX insider transactions
Akari Therapeutics plc (AKTX) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for AKTX
- SEC Form 4 filed by Director Neal James R4 - Akari Therapeutics Plc (0001541157) (Issuer)
- SEC Form 4 filed by Director Prudo-Chlebosz Raymond4 - Akari Therapeutics Plc (0001541157) (Issuer)
- SEC Form 4 filed by Director Patel Sandip I4 - Akari Therapeutics Plc (0001541157) (Issuer)
- SEC Form 4 filed by Director Huh Hoyoung4 - Akari Therapeutics Plc (0001541157) (Issuer)
- SEC Form 4 filed by Interim CFO Farag Kameel D.4 - Akari Therapeutics Plc (0001541157) (Issuer)
- SEC Form 4 filed by Director Patel Samir Rashmikant4 - Akari Therapeutics Plc (0001541157) (Issuer)
- SEC Form 4 filed by Director Bazemore Robert B4 - Akari Therapeutics Plc (0001541157) (Issuer)
- SEC Form 4 filed by CEO Gaslightwala Abizer4 - Akari Therapeutics Plc (0001541157) (Issuer)
- Interim CFO Farag Kameel D. was granted 58,619 units of American Depositary Shares representing Ordinary Shares (SEC Form 4)4 - Akari Therapeutics Plc (0001541157) (Issuer)
- Interim CFO Farag Kameel D. was granted 6,277 units of American Depositary Shares representing Ordinary Shares (SEC Form 4)4 - Akari Therapeutics Plc (0001541157) (Issuer)
- SEC Form 3 filed by new insider Farag Kameel D.3 - Akari Therapeutics Plc (0001541157) (Issuer)
- CEO Gaslightwala Abizer bought $19,540 worth of American Depositary Shares representing Ordinary Shares (21,000 units at $0.93), increasing direct ownership by 8% to 298,574 units (SEC Form 4)4 - Akari Therapeutics Plc (0001541157) (Issuer)
- President & CEO Gaslightwala Abizer bought $7,120 worth of American Depositary Shares representing Ordinary Shares (6,146 units at $1.16), increasing direct ownership by 2% to 277,574 units (SEC Form 4)4 - Akari Therapeutics Plc (0001541157) (Issuer)
- President & CEO Gaslightwala Abizer bought $12,000 worth of American Depositary Shares representing Ordinary Shares (10,000 units at $1.20), increasing direct ownership by 4% to 271,428 units (SEC Form 4)4 - Akari Therapeutics Plc (0001541157) (Issuer)
- President & CEO Gaslightwala Abizer bought $18,000 worth of American Depositary Shares representing Ordinary Shares (15,000 units at $1.20), increasing direct ownership by 6% to 261,428 units (SEC Form 4)4 - Akari Therapeutics Plc (0001541157) (Issuer)
- CEO Gaslightwala Abizer was granted 45,000 units of American Depositary Shares representing Ordinary Shares, increasing direct ownership by 22% to 246,428 units (SEC Form 4)4 - Akari Therapeutics Plc (0001541157) (Issuer)
- CEO Gaslightwala Abizer was granted 20,000 units of American Depositary Shares representing Ordinary Shares, increasing direct ownership by 11% to 201,428 units (SEC Form 4)4 - Akari Therapeutics Plc (0001541157) (Issuer)
- Director Patel Sandip I was granted 44,642 units of American Depositary Shares representing Ordinary Shares, increasing direct ownership by 10% to 496,499 units (SEC Form 4)4 - Akari Therapeutics Plc (0001541157) (Issuer)
- SEC Form 4 filed by Director Bazemore Robert B4 - Akari Therapeutics Plc (0001541157) (Issuer)
- SEC Form 4 filed by Director Neal James R4 - Akari Therapeutics Plc (0001541157) (Issuer)
- SEC Form 4 filed by Director Patel Sandip I4 - Akari Therapeutics Plc (0001541157) (Issuer)
- SEC Form 4 filed by Director Prudo-Chlebosz Raymond4 - Akari Therapeutics Plc (0001541157) (Issuer)
- SEC Form 4 filed by Director Patel Samir Rashmikant4 - Akari Therapeutics Plc (0001541157) (Issuer)
- SEC Form 4 filed by Director Gaslightwala Abizer4 - Akari Therapeutics Plc (0001541157) (Issuer)
- SEC Form 4 filed by CFO Hombeck Torsten4 - Akari Therapeutics Plc (0001541157) (Issuer)
- SEC Form 4 filed by Director Huh Hoyoung4 - Akari Therapeutics Plc (0001541157) (Issuer)
- Director Huh Hoyoung was granted 892,857 units of American Depositary Shares representing Ordinary Shares, increasing direct ownership by 23% to 4,695,854 units (SEC Form 4)4 - Akari Therapeutics Plc (0001541157) (Issuer)
- Director Prudo-Chlebosz Raymond was granted 446,428 units of American Depositary Shares representing Ordinary Shares, increasing direct ownership by 22% to 2,484,990 units (SEC Form 4)4 - Akari Therapeutics Plc (0001541157) (Issuer)
- Director Patel Samir Rashmikant was granted 406,250 units of American Depositary Shares representing Ordinary Shares (SEC Form 4)4 - Akari Therapeutics Plc (0001541157) (Issuer)
- Director Bazemore Robert B was granted 44,642 units of American Depositary Shares representing Ordinary Shares (SEC Form 4)4 - Akari Therapeutics Plc (0001541157) (Issuer)
- Director Neal James R was granted 4,464 units of American Depositary Shares representing Ordinary Shares, increasing direct ownership by 14% to 36,271 units (SEC Form 4)4 - Akari Therapeutics Plc (0001541157) (Issuer)
- Director Gaslightwala Abizer was granted 133,928 units of American Depositary Shares representing Ordinary Shares, increasing direct ownership by 282% to 181,428 units (SEC Form 4)4 - Akari Therapeutics Plc (0001541157) (Issuer)
- Amendment: Director Gaslightwala Abizer was granted 11,640 units of American Depository Shares representing Ordinary Shares, increasing direct ownership by 32% to 47,500 units (SEC Form 4)4/A - Akari Therapeutics Plc (0001541157) (Issuer)
- Director Gaslightwala Abizer was granted 11,439 units of American Depository Shares representing Ordinary Shares, increasing direct ownership by 47% to 35,860 units (SEC Form 4)4 - Akari Therapeutics Plc (0001541157) (Issuer)
- CFO Hombeck Torsten was granted 200 units of American Depository Shares representing Ordinary Shares (SEC Form 4)4 - Akari Therapeutics Plc (0001541157) (Issuer)
- Director Neal James R was granted 8,000,000 units of Ordinary Shares, increasing direct ownership by 33% to 32,216,000 units (SEC Form 4)4 - Akari Therapeutics Plc (0001541157) (Issuer)
- Director Gaslightwala Abizer was granted 1,720,000 units of Ordinary Shares, increasing direct ownership by 2% to 71,720,000 units (SEC Form 4)4 - Akari Therapeutics Plc (0001541157) (Issuer)
- Director Patel Samir Rashmikant was granted 208,000 units of Ordinary Shares (SEC Form 4)4 - Akari Therapeutics Plc (0001541157) (Issuer)
- Director Patel Samir Rashmikant was granted 3,600,000 units of Ordinary Shares (SEC Form 4)4 - Akari Therapeutics Plc (0001541157) (Issuer)
- Director Gaslightwala Abizer was granted 40,000,000 units of Ordinary Shares, increasing direct ownership by 133% to 70,000,000 units (SEC Form 4)4 - Akari Therapeutics Plc (0001541157) (Issuer)
- Director Gaslightwala Abizer was granted 30,000,000 units of Ordinary Shares (SEC Form 4)4 - Akari Therapeutics Plc (0001541157) (Issuer)
- Director Patel Samir Rashmikant was granted 7,500,000 units of Ordinary Shares (SEC Form 4)4 - Akari Therapeutics Plc (0001541157) (Issuer)
- Director Patel Samir Rashmikant was granted 1,400,000 units of Ordinary Shares (SEC Form 4)4 - Akari Therapeutics Plc (0001541157) (Issuer)
- Director Patel Samir Rashmikant was granted 1,400,000 units of Ordinary Shares (SEC Form 4)4 - Akari Therapeutics Plc (0001541157) (Issuer)
- Director Neal James R was granted 2,000,000 units of Ordinary Shares, increasing direct ownership by 9% to 24,216,000 units (SEC Form 4)4 - Akari Therapeutics Plc (0001541157) (Issuer)
- SEC Form 3 filed by new insider Gaslightwala Abizer3 - Akari Therapeutics Plc (0001541157) (Issuer)
- SEC Form 3 filed by new insider Hombeck Torsten3 - Akari Therapeutics Plc (0001541157) (Issuer)
- Director Patel Samir Rashmikant was granted 419,286,000 units of Ordinary Shares (SEC Form 4)4 - Akari Therapeutics Plc (0001541157) (Issuer)
- Director Prudo-Chlebosz Raymond was granted 419,286,000 units of Ordinary Shares, increasing direct ownership by 11% to 4,077,124,600 units (SEC Form 4)4 - Akari Therapeutics Plc (0001541157) (Issuer)
- New insider Neal James R claimed ownership of 22,216,000 units of Ordinary Shares (SEC Form 3)3 - Akari Therapeutics Plc (0001541157) (Issuer)
- New insider Huh Hoyoung claimed ownership of 7,824,908,000 units of Ordinary Shares (SEC Form 3)3 - Akari Therapeutics Plc (0001541157) (Issuer)
- New insider Patel Sandip I claimed ownership of 1,024,214,000 units of Ordinary Shares (SEC Form 3)3 - Akari Therapeutics Plc (0001541157) (Issuer)
- Director Patel Samir Rashmikant was granted 1,404,622,000 units of Ordinary Shares (SEC Form 4)4 - Akari Therapeutics Plc (0001541157) (Issuer)
- SEC Form 4 filed by Director Patel Samir Rashmikant4 - Akari Therapeutics Plc (0001541157) (Issuer)
- SEC Form 4 filed by Director Patel Samir Rashmikant4 - Akari Therapeutics Plc (0001541157) (Issuer)
- SEC Form 4 filed by Director Bazemore Robert B4 - Akari Therapeutics Plc (0001541157) (Issuer)
- SEC Form 3 filed by new insider Bazemore Robert B3 - Akari Therapeutics Plc (0001541157) (Issuer)
- SEC Form 4 filed by Director Grissinger Michael4 - Akari Therapeutics Plc (0001541157) (Issuer)
- SEC Form 4 filed by Director Williams Donald A4 - Akari Therapeutics Plc (0001541157) (Issuer)
- SEC Form 4 filed by Director Hashad Mohamed Wa'El Ahmed4 - Akari Therapeutics Plc (0001541157) (Issuer)